相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhancing the oral bioavailability of simvastatin with silica -lipid hybrid particles: The effect of supersaturation and silica geometry
Tahlia R. Meola et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro
Tahlia R. Meola et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Engineering intelligent particle-lipid composites that control lipase-mediated digestion
Paul Joyce et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2018)
Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro
Tahnee J. Dening et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Development and Validation of an LC-MS-MS Method for Determination of Simvastatin and Simvastatin Acid in Human Plasma: Application to a Pharmacokinetic Study
Pankaj Partani et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2016)
Porous nanostructure controls kinetics, disposition and self-assembly structure of lipid digestion products
Paul Joyce et al.
RSC ADVANCES (2016)
Interfacial processes that modulate the kinetics of lipase-mediated catalysis using porous silica host particles
Paul Joyce et al.
RSC ADVANCES (2016)
Synthesis, Characterization, Drug Solubility Enhancement, and Drug Release Study of Poly(Methacrylic Acid-graft-Simvastatin)
Bohaissa Mohamad Alam et al.
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS (2015)
The Role of Porous Nanostructure in Controlling Lipase-Mediated Digestion of Lipid Loaded into Silica Particles
Paul Joyce et al.
LANGMUIR (2014)
First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen
Angel Tan et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)
Supersaturated Self-Nanoemulsifying Drug Delivery Systems (Super-SNEDDS) Enhance the Bioavailability of the Poorly Water-Soluble Drug Simvastatin in Dogs
Nicky Thomas et al.
AAPS JOURNAL (2013)
Bioequivalence Requirements in the European Union: Critical Discussion
Alfredo Garcia-Arieta et al.
AAPS JOURNAL (2012)
Genetic contribution to variable human CYP3A-mediated metabolism
Jatinder K. Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
A comparison of lipase and trypsin encapsulated in mesoporous materials with varying pore sizes and pH conditions
Hanna Gustafsson et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
Paivi Kinnari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake
Radheshyam Tiwari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Can a Statin Neutralize the Cardiovascular Risk of Unhealthy Dietary Choices?
Emily A. Ferenczi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats
Zhiwen Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs
Angel Tan et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed Versus immediate release oral dosage forms
Marija Tubic-Grozdanis et al.
PHARMACEUTICAL RESEARCH (2008)
The impact of medication regimen factors on adherence to chronic treatment: a review of literature
Karen S. Ingersoll et al.
JOURNAL OF BEHAVIORAL MEDICINE (2008)
Oral lipid-based formulations
David J. Hauss
ADVANCED DRUG DELIVERY REVIEWS (2007)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs
BK Kang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Simvastatin: a review
TR Pedersen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6
T Prueksaritanont et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam
T Sawada et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
B Agoram et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Current perspectives on statins
DJ Maron et al.
CIRCULATION (2000)
分享论文
